Potassium Salt [EPC]

Potassium Salt [EPC] was reported 93830 times

These side effects are most commonly reported by patients taking drugs of the Potassium Salt [EPC] class:

# Drug class Count
0 DIARRHOEA 6881
1 DYSPNOEA 6837
2 NAUSEA 6625
3 FATIGUE 6409
4 DEATH 4664
5 PNEUMONIA 4543
6 HEADACHE 4283
7 VOMITING 4213
8 ASTHENIA 4203
9 OFF LABEL USE 4119
10 DIZZINESS 4045
11 PAIN 3918
12 FALL 3686
13 DRUG INEFFECTIVE 3638
14 ANAEMIA 3173
15 HYPOTENSION 3157
16 PYREXIA 3157
17 WEIGHT DECREASED 2991
18 MALAISE 2941
19 COUGH 2895
20 ACUTE KIDNEY INJURY 2775
21 CONSTIPATION 2622
22 ABDOMINAL PAIN 2476
23 OEDEMA PERIPHERAL 2462
24 ARTHRALGIA 2433
25 DECREASED APPETITE 2393
26 PAIN IN EXTREMITY 2309
27 DEHYDRATION 2195
28 ATRIAL FIBRILLATION 2190
29 BACK PAIN 2165
30 RASH 2162
31 CARDIAC FAILURE CONGESTIVE 2133
32 RENAL FAILURE 2127
33 URINARY TRACT INFECTION 2103
34 CONDITION AGGRAVATED 2051
35 HYPOKALAEMIA 2044
36 SEPSIS 2015
37 CHEST PAIN 2002
38 ANXIETY 1942
39 HYPERTENSION 1923
40 PRURITUS 1902
41 WEIGHT INCREASED 1702
42 PERIPHERAL SWELLING 1697
43 SOMNOLENCE 1672
44 DEPRESSION 1602
45 INSOMNIA 1599
46 PRODUCT DOSE OMISSION ISSUE 1568
47 GASTROINTESTINAL HAEMORRHAGE 1531
48 FEELING ABNORMAL 1513
49 ABDOMINAL PAIN UPPER 1481
50 CONFUSIONAL STATE 1478
51 DRUG INTERACTION 1467
52 CHRONIC KIDNEY DISEASE 1448
53 HAEMOGLOBIN DECREASED 1388
54 MUSCLE SPASMS 1353
55 PLATELET COUNT DECREASED 1334
56 GAIT DISTURBANCE 1331
57 THROMBOCYTOPENIA 1322
58 CARDIAC FAILURE 1281
59 RESPIRATORY FAILURE 1281
60 FLUID RETENTION 1278
61 MYOCARDIAL INFARCTION 1268
62 PLEURAL EFFUSION 1260
63 BRONCHITIS 1239
64 ABDOMINAL DISTENSION 1234
65 FEBRILE NEUTROPENIA 1229
66 NEUTROPENIA 1196
67 GASTROOESOPHAGEAL REFLUX DISEASE 1183
68 BLOOD GLUCOSE INCREASED 1176
69 BLOOD PRESSURE INCREASED 1171
70 ERYTHEMA 1169
71 GENERAL PHYSICAL HEALTH DETERIORATION 1164
72 TREMOR 1160
73 SYNCOPE 1148
74 COVID-19 1143
75 DRUG HYPERSENSITIVITY 1140
76 ABDOMINAL DISCOMFORT 1139
77 BLOOD POTASSIUM DECREASED 1137
78 HYPERKALAEMIA 1129
79 WHITE BLOOD CELL COUNT DECREASED 1127
80 CEREBROVASCULAR ACCIDENT 1122
81 NASOPHARYNGITIS 1112
82 HYPONATRAEMIA 1110
83 CARDIAC ARREST 1074
84 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1072
85 INFECTION 1050
86 EPISTAXIS 1043
87 PULMONARY EMBOLISM 1017
88 NEUROPATHY PERIPHERAL 1007
89 OXYGEN SATURATION DECREASED 1001
90 PRODUCT USE IN UNAPPROVED INDICATION 999
91 PALPITATIONS 987
92 MYALGIA 983
93 CONTUSION 981
94 MUSCULAR WEAKNESS 970
95 DISEASE PROGRESSION 967
96 ALOPECIA 961
97 CHEST DISCOMFORT 961
98 HYPOAESTHESIA 961
99 SINUSITIS 958
100 BLOOD CREATININE INCREASED 957
101 CHILLS 956
102 OEDEMA 952
103 DYSPNOEA EXERTIONAL 934
104 DYSPEPSIA 928
105 RENAL FAILURE ACUTE 928
106 HYPERHIDROSIS 927
107 TACHYCARDIA 925
108 LOSS OF CONSCIOUSNESS 921
109 HEART RATE INCREASED 880
110 CELLULITIS 860
111 INFLUENZA 856
112 HYPOXIA 840
113 PANCYTOPENIA 835
114 PARAESTHESIA 832
115 FLUSHING 829
116 PRODUCT USE ISSUE 829
117 THROMBOSIS 823
118 SWELLING 822
119 VISION BLURRED 822
120 CARDIAC DISORDER 819
121 MEMORY IMPAIRMENT 809
122 HOSPITALISATION 801
123 BLOOD PRESSURE DECREASED 792
124 ILLNESS 780
125 JOINT SWELLING 778
126 PULMONARY OEDEMA 774
127 DYSPHAGIA 772
128 RENAL IMPAIRMENT 767
129 DEEP VEIN THROMBOSIS 753
130 ASTHMA 740
131 HYPERSENSITIVITY 740
132 PULMONARY HYPERTENSION 738
133 DRUG INTOLERANCE 727
134 RECTAL HAEMORRHAGE 727
135 DRY MOUTH 723
136 SEPTIC SHOCK 718
137 PRODUCTIVE COUGH 715
138 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 712
139 ASCITES 707
140 BRADYCARDIA 707
141 BALANCE DISORDER 701
142 HAEMORRHAGE 692
143 DIABETES MELLITUS 689
144 HALLUCINATION 682
145 INJECTION SITE PAIN 674
146 STRESS 674
147 ASPARTATE AMINOTRANSFERASE INCREASED 663
148 INTERNATIONAL NORMALISED RATIO INCREASED 662
149 INCORRECT DOSE ADMINISTERED 658
150 TOXICITY TO VARIOUS AGENTS 654
151 ALANINE AMINOTRANSFERASE INCREASED 653
152 OROPHARYNGEAL PAIN 650
153 UNEVALUABLE EVENT 637
154 URTICARIA 637
155 GASTROINTESTINAL DISORDER 635
156 INJURY 634
157 MIGRAINE 618
158 UPPER RESPIRATORY TRACT INFECTION 618
159 ACUTE RESPIRATORY FAILURE 605
160 OVERDOSE 602
161 VISUAL IMPAIRMENT 595
162 HAEMATOCHEZIA 591
163 MALIGNANT NEOPLASM PROGRESSION 589
164 COMA 588
165 ARTHRITIS 586
166 NASAL CONGESTION 585
167 COLITIS 581
168 INFUSION RELATED REACTION 577
169 STOMATITIS 575
170 PNEUMONIA ASPIRATION 567
171 WHEEZING 558
172 MENTAL STATUS CHANGES 548
173 INFUSION SITE PAIN 537
174 DRY SKIN 534
175 EMOTIONAL DISTRESS 531
176 ARRHYTHMIA 527
177 HYPOGLYCAEMIA 525
178 SEIZURE 525
179 COMPLETED SUICIDE 516
180 SLEEP DISORDER 516
181 CYSTITIS 514
182 AGITATION 504
183 LETHARGY 502
184 DRUG DOSE OMISSION 499
185 DIVERTICULITIS 498
186 CORONARY ARTERY DISEASE 497
187 NECK PAIN 491
188 C-REACTIVE PROTEIN INCREASED 489
189 PAIN IN JAW 488
190 CYTOKINE RELEASE SYNDROME 486
191 END STAGE RENAL DISEASE 484
192 CATARACT 483
193 DYSPHONIA 482
194 LUNG DISORDER 481
195 MULTIPLE ORGAN DYSFUNCTION SYNDROME 479
196 MOBILITY DECREASED 476
197 CARDIOGENIC SHOCK 474
198 RHINORRHOEA 469
199 MUSCULOSKELETAL PAIN 455
200 RHEUMATOID ARTHRITIS 454
201 NEUTROPHIL COUNT DECREASED 451
202 FLATULENCE 445
203 HYPERGLYCAEMIA 445
204 OSTEOARTHRITIS 444
205 BLOOD BILIRUBIN INCREASED 443
206 HEPATIC ENZYME INCREASED 438
207 CARDIO-RESPIRATORY ARREST 436
208 PERICARDIAL EFFUSION 436
209 BLOOD UREA INCREASED 435
210 HERPES ZOSTER 434
211 SEASONAL ALLERGY 432
212 AMNESIA 431
213 MUSCULOSKELETAL STIFFNESS 431
214 TRANSIENT ISCHAEMIC ATTACK 430
215 HOT FLUSH 427
216 INTENTIONAL PRODUCT MISUSE 427
217 WHITE BLOOD CELL COUNT INCREASED 426
218 MACULAR DEGENERATION 423
219 RESPIRATORY DISTRESS 421
220 FLUID OVERLOAD 420
221 ELECTROCARDIOGRAM QT PROLONGED 419
222 RENAL INJURY 417
223 GOUT 416
224 BLOOD CHOLESTEROL INCREASED 414
225 CHOLELITHIASIS 414
226 OSTEOPOROSIS 414
227 CARDIOMEGALY 411
228 BLISTER 409
229 BONE PAIN 409
230 HAEMOPTYSIS 408
231 BLOOD ALKALINE PHOSPHATASE INCREASED 405
232 THERAPY NON-RESPONDER 405
233 HAEMATOCRIT DECREASED 404
234 VENTRICULAR FIBRILLATION 403
235 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 403
236 HYPOMAGNESAEMIA 401
237 STAPHYLOCOCCAL INFECTION 400
238 ECONOMIC PROBLEM 397
239 PLASMA CELL MYELOMA 395
240 PULMONARY ARTERIAL HYPERTENSION 393
241 THROAT IRRITATION 391
242 TREATMENT NONCOMPLIANCE 389
243 DYSGEUSIA 388
244 HYPERLIPIDAEMIA 388
245 RENAL DISORDER 384
246 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 384
247 SLEEP APNOEA SYNDROME 382
248 MITRAL VALVE INCOMPETENCE 380
249 VENTRICULAR TACHYCARDIA 380
250 HEAD INJURY 379
251 INTENTIONAL PRODUCT USE ISSUE 378
252 SWELLING FACE 375
253 DYSURIA 374
254 HAEMATURIA 374
255 THERAPY INTERRUPTED 373
256 RED BLOOD CELL COUNT DECREASED 371
257 NEPHROLITHIASIS 370
258 EYE PAIN 366
259 LEUKOPENIA 366
260 ATELECTASIS 365
261 ACUTE MYOCARDIAL INFARCTION 363
262 SKIN EXFOLIATION 361
263 TOXIC EPIDERMAL NECROLYSIS 358
264 ENCEPHALOPATHY 352
265 INTERSTITIAL LUNG DISEASE 352
266 HAEMATOMA 347
267 TINNITUS 346
268 UPPER GASTROINTESTINAL HAEMORRHAGE 346
269 ANHEDONIA 344
270 INFLUENZA LIKE ILLNESS 343
271 ORAL CANDIDIASIS 342
272 PANCREATITIS 342
273 VERTIGO 342
274 BACTERIAL INFECTION 341
275 BURNING SENSATION 340
276 FEELING HOT 340
277 PRODUCT DOSE OMISSION 340
278 ADVERSE DRUG REACTION 336
279 HYPOTHYROIDISM 336
280 PROCEDURAL PAIN 336
281 MEDICATION ERROR 335
282 CONVULSION 334
283 INFUSION SITE ERYTHEMA 334
284 BLOOD GLUCOSE DECREASED 328
285 HEART RATE DECREASED 328
286 POLLAKIURIA 328
287 RASH PRURITIC 328
288 FREQUENT BOWEL MOVEMENTS 327
289 BLOOD POTASSIUM INCREASED 326
290 ELECTROLYTE IMBALANCE 325
291 SKIN DISCOLOURATION 324
292 UNRESPONSIVE TO STIMULI 323
293 URINARY RETENTION 323
294 DEMENTIA 322
295 LEUKOCYTOSIS 322
296 RHABDOMYOLYSIS 321
297 LABORATORY TEST ABNORMAL 318
298 ARTHROPATHY 317
299 HYPOCALCAEMIA 315
300 COAGULOPATHY 314
301 NEURALGIA 314
302 ADVERSE EVENT 312
303 HEART RATE IRREGULAR 311
304 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 309
305 ORTHOSTATIC HYPOTENSION 309
306 GLAUCOMA 308
307 RIGHT VENTRICULAR FAILURE 307
308 SPEECH DISORDER 307
309 INTESTINAL OBSTRUCTION 306
310 MELAENA 306
311 DYSARTHRIA 305
312 INJECTION SITE ERYTHEMA 304
313 METABOLIC ACIDOSIS 302
314 CARDIOMYOPATHY 301
315 PRESYNCOPE 301
316 BLOOD SODIUM DECREASED 299
317 HIP FRACTURE 297
318 LACTIC ACIDOSIS 295
319 NERVOUSNESS 295
320 DISORIENTATION 294
321 FIBROMYALGIA 293
322 DELIRIUM 290
323 LIVER DISORDER 290
324 TREATMENT FAILURE 290
325 GASTRITIS 288
326 CLOSTRIDIUM DIFFICILE COLITIS 286
327 ILL-DEFINED DISORDER 286
328 HEPATIC FAILURE 284
329 LYMPHOEDEMA 284
330 CEREBRAL HAEMORRHAGE 283
331 PRODUCT QUALITY ISSUE 283
332 PNEUMONITIS 282
333 URINARY INCONTINENCE 282
334 COLITIS ULCERATIVE 280
335 FULL BLOOD COUNT DECREASED 280
336 HYPOPHOSPHATAEMIA 280
337 HAEMORRHOIDS 279
338 PARAESTHESIA ORAL 279
339 HYPOPHAGIA 278
340 VIRAL INFECTION 277
341 FUNGAL INFECTION 274
342 LOCALISED INFECTION 272
343 SURGERY 272
344 TYPE 2 DIABETES MELLITUS 272
345 MULTI-ORGAN FAILURE 271
346 APPENDICITIS 270
347 COGNITIVE DISORDER 270
348 DEVICE ISSUE 265
349 CLOSTRIDIUM DIFFICILE INFECTION 264
350 DEPRESSED LEVEL OF CONSCIOUSNESS 264
351 DERMATITIS CONTACT 264
352 EJECTION FRACTION DECREASED 264
353 LYMPHOCYTE COUNT DECREASED 264
354 CHRONIC SINUSITIS 262
355 NEPHROGENIC ANAEMIA 262
356 RESPIRATORY TRACT INFECTION 262
357 HYPERVOLAEMIA 260
358 RASH ERYTHEMATOUS 259
359 GENERALISED OEDEMA 258
360 SKIN ULCER 258
361 TRICUSPID VALVE INCOMPETENCE 257
362 DISCOMFORT 256
363 ATRIAL FLUTTER 255
364 LIMB INJURY 254
365 ANAPHYLACTIC REACTION 252
366 EYE IRRITATION 251
367 HYPERSOMNIA 250
368 LIVER FUNCTION TEST ABNORMAL 250
369 BLOOD MAGNESIUM DECREASED 249
370 LOWER RESPIRATORY TRACT INFECTION 249
371 PSORIASIS 247
372 NEOPLASM MALIGNANT 245
373 UNDERDOSE 244
374 HYPOACUSIS 243
375 RADICULOPATHY 243
376 MALNUTRITION 240
377 MUCOSAL INFLAMMATION 239
378 VENTRICULAR EXTRASYSTOLES 239
379 APHASIA 238
380 HIATUS HERNIA 238
381 INFUSION SITE SWELLING 238
382 MATERNAL EXPOSURE DURING PREGNANCY 238
383 ULCER 236
384 TACHYPNOEA 235
385 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 232
386 DRY EYE 231
387 FEAR 231
388 INFLAMMATION 231
389 SINUS DISORDER 231
390 RESPIRATORY DISORDER 230
391 ROAD TRAFFIC ACCIDENT 230
392 ANGINA PECTORIS 229
393 JOINT INJURY 226
394 BACTERAEMIA 225
395 NO ADVERSE EVENT 225
396 SMALL INTESTINAL OBSTRUCTION 225
397 TASTE DISORDER 225
398 LYMPHADENOPATHY 224
399 OBESITY 224
400 SYNOVITIS 224
401 DEVICE RELATED INFECTION 223
402 OCULAR HYPERAEMIA 221
403 DEVICE MALFUNCTION 220
404 RESPIRATORY ARREST 220
405 HEPATIC CYTOLYSIS 218
406 LUNG INFILTRATION 218
407 RIB FRACTURE 218
408 CARDIAC MURMUR 216
409 DISTURBANCE IN ATTENTION 216
410 INTERVERTEBRAL DISC PROTRUSION 216
411 GAMMA-GLUTAMYLTRANSFERASE INCREASED 214
412 HAEMATEMESIS 214
413 MYASTHENIA GRAVIS 214
414 PULMONARY MASS 214
415 SHOCK 214
416 FEELING COLD 213
417 HEPATIC CIRRHOSIS 213
418 RALES 213
419 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 212
420 COLITIS MICROSCOPIC 212
421 RESTLESSNESS 212
422 APPENDICOLITH 211
423 PANCREATITIS ACUTE 209
424 SINUS TACHYCARDIA 209
425 DYSSTASIA 208
426 HEPATIC FUNCTION ABNORMAL 208
427 JAUNDICE 207
428 BLOOD PRESSURE ABNORMAL 206
429 NIGHT SWEATS 206
430 FAECES DISCOLOURED 205
431 GASTRIC ULCER 205
432 LACRIMATION INCREASED 205
433 RETCHING 205
434 INTENTIONAL OVERDOSE 204
435 ORAL PAIN 204
436 THERAPEUTIC RESPONSE DECREASED 204
437 TUBULOINTERSTITIAL NEPHRITIS 204
438 BLOOD ALBUMIN DECREASED 203
439 GASTRIC DISORDER 203
440 RASH MACULO-PAPULAR 203
441 EAR INFECTION 202
442 IRON DEFICIENCY ANAEMIA 202
443 FEMUR FRACTURE 201
444 FEMALE GENITAL TRACT FISTULA 200
445 PULMONARY CONGESTION 200
446 DEPRESSED MOOD 199
447 HYPOVOLAEMIA 199
448 PROCTITIS 199
449 DIABETES MELLITUS INADEQUATE CONTROL 198
450 GAIT INABILITY 198
451 HEPATIC STEATOSIS 198
452 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 198
453 LIMB DISCOMFORT 196
454 SUBDURAL HAEMATOMA 196
455 BREAST CANCER 195
456 POST PROCEDURAL COMPLICATION 195
457 RENAL FAILURE CHRONIC 195
458 ACCIDENTAL OVERDOSE 194
459 BREATH SOUNDS ABNORMAL 194
460 EYE SWELLING 194
461 RESPIRATORY TRACT CONGESTION 194
462 TRANSFUSION 194
463 VASCULAR DEVICE INFECTION 194
464 ACUTE RESPIRATORY DISTRESS SYNDROME 193
465 CANDIDA INFECTION 193
466 KIDNEY INFECTION 193
467 SKIN LESION 193
468 DEVICE DISLOCATION 192
469 EMPHYSEMA 192
470 MULTIPLE INJURIES 192
471 THERAPY CESSATION 192
472 BLOOD PRESSURE SYSTOLIC INCREASED 191
473 LOWER GASTROINTESTINAL HAEMORRHAGE 191
474 PALLOR 191
475 RASH MACULAR 191
476 VAGINAL DISCHARGE 191
477 MULTIPLE ALLERGIES 190
478 RENAL TUBULAR NECROSIS 190
479 BLINDNESS 189
480 CONTRAINDICATED PRODUCT ADMINISTERED 189
481 HERNIA 189
482 TROPONIN INCREASED 189
483 INJECTION SITE HAEMORRHAGE 188
484 OESOPHAGITIS 188
485 AGEUSIA 187
486 ECZEMA 187
487 FOETAL EXPOSURE DURING PREGNANCY 187
488 ILEUS 187
489 STEVENS-JOHNSON SYNDROME 187
490 TRANSAMINASES INCREASED 187
491 ABASIA 186
492 CIRCULATORY COLLAPSE 186
493 GASTROENTERITIS 186
494 IMPAIRED HEALING 186
495 MENTAL DISORDER 186
496 SUICIDAL IDEATION 186
497 ELECTROCARDIOGRAM ABNORMAL 184
498 HOSPICE CARE 184
499 VAGINAL FLATULENCE 184
500 DRUG DEPENDENCE 183
501 IRRITABILITY 183
502 MULTIPLE SCLEROSIS RELAPSE 183
503 DYSKINESIA 182
504 INJECTION SITE PRURITUS 182
505 LIVER FUNCTION TEST INCREASED 182
506 LUNG INFECTION 182
507 AGRANULOCYTOSIS 181
508 CHOLESTASIS 180
509 GASTROENTERITIS VIRAL 180
510 BLOOD PRESSURE FLUCTUATION 179
511 INJECTION SITE BRUISING 179
512 SCIATICA 179
513 THYROID DISORDER 179
514 BLOOD URIC ACID INCREASED 178
515 BONE MARROW FAILURE 178
516 EYE DISORDER 178
517 FEEDING DISORDER 178
518 WOUND 178
519 ARTERIOSCLEROSIS 177
520 MOUTH ULCERATION 177
521 THERAPEUTIC RESPONSE UNEXPECTED 177
522 AORTIC STENOSIS 176
523 BLOOD PHOSPHORUS INCREASED 176
524 BLOOD TEST ABNORMAL 176
525 DEVICE LEAKAGE 175
526 HAEMORRHAGIC ANAEMIA 175
527 SUPRAVENTRICULAR TACHYCARDIA 175
528 ADRENAL INSUFFICIENCY 174
529 COVID-19 PNEUMONIA 174
530 HYPERPHOSPHATAEMIA 174
531 RESTLESS LEGS SYNDROME 174
532 OSTEOMYELITIS 173
533 PROTHROMBIN TIME PROLONGED 173
534 HYPERCALCAEMIA 172
535 BLOOD CREATINE PHOSPHOKINASE INCREASED 171
536 HYPOALBUMINAEMIA 171
537 INFUSION SITE HAEMORRHAGE 170
538 BLOOD URINE PRESENT 168
539 DIPLOPIA 168
540 ORTHOPNOEA 168
541 PREMATURE BABY 167
542 SKIN LACERATION 167
543 HAEMOGLOBIN INCREASED 166
544 ARTERIOSCLEROSIS CORONARY ARTERY 165
545 SWOLLEN TONGUE 163
546 BODY TEMPERATURE INCREASED 162
547 BLOOD CALCIUM DECREASED 161
548 DIVERTICULUM 161
549 FAILURE TO THRIVE 161
550 CYANOSIS 160
551 DISEASE RECURRENCE 160
552 GALLBLADDER DISORDER 160
553 PRODUCT DOSE OMISSION IN ERROR 160
554 CEREBRAL INFARCTION 159
555 MUSCULOSKELETAL CHEST PAIN 159
556 PANIC ATTACK 159
557 PNEUMOTHORAX 159
558 SKIN DISORDER 159
559 UROSEPSIS 159
560 INTENTIONAL DOSE OMISSION 158
561 NEOPLASM PROGRESSION 158
562 NERVOUS SYSTEM DISORDER 158
563 ACUTE MYELOID LEUKAEMIA 157
564 DEVICE OCCLUSION 156
565 PULMONARY FIBROSIS 156
566 SPINAL FRACTURE 156
567 BLOOD IRON DECREASED 155
568 CROHN^S DISEASE 155
569 EAR PAIN 155
570 FOOT FRACTURE 155
571 BODY HEIGHT DECREASED 154
572 ASPIRATION 153
573 CARDIAC FAILURE ACUTE 153
574 IRON DEFICIENCY 153
575 LUNG NEOPLASM MALIGNANT 153
576 PHARMACEUTICAL PRODUCT COMPLAINT 153
577 SINUS CONGESTION 153
578 SPINAL OSTEOARTHRITIS 153
579 ANGIOEDEMA 152
580 CHOLECYSTITIS 152
581 GLOMERULAR FILTRATION RATE DECREASED 152
582 DRUG-INDUCED LIVER INJURY 151
583 HYPERPARATHYROIDISM SECONDARY 151
584 IMPAIRED GASTRIC EMPTYING 151
585 LIP SWELLING 151
586 MYELOSUPPRESSION 151
587 UPPER LIMB FRACTURE 151
588 EATING DISORDER 150
589 INTERNAL HAEMORRHAGE 150
590 DECUBITUS ULCER 149
591 HYPERCHOLESTEROLAEMIA 149
592 LEFT VENTRICULAR DYSFUNCTION 149
593 OSTEOPENIA 149
594 SINUS BRADYCARDIA 149
595 THERAPEUTIC AGENT TOXICITY 149
596 THERAPEUTIC PRODUCT EFFECT DECREASED 148
597 TOOTH DISORDER 148
598 CARDIOVASCULAR DISORDER 147
599 DISSEMINATED INTRAVASCULAR COAGULATION 147
600 PERITONITIS 146
601 VAGINAL HAEMORRHAGE 146
602 CORONARY ARTERY OCCLUSION 145
603 HAEMORRHAGE INTRACRANIAL 145
604 MUSCULOSKELETAL DISCOMFORT 145
605 AGGRESSION 144
606 HALLUCINATION, VISUAL 144
607 HEMIPARESIS 144
608 HYPERTHYROIDISM 144
609 VISUAL ACUITY REDUCED 144
610 BLOOD LACTATE DEHYDROGENASE INCREASED 143
611 PRODUCT ADMINISTRATION ERROR 143
612 BONE DISORDER 142
613 ABSCESS 141
614 SKIN REACTION 141
615 SNEEZING 141
616 SUICIDE ATTEMPT 141
617 ANKLE FRACTURE 140
618 BLOOD CALCIUM INCREASED 140
619 BLOOD TRIGLYCERIDES INCREASED 140
620 MYOCARDIAL ISCHAEMIA 140
621 ATRIOVENTRICULAR BLOCK FIRST DEGREE 139
622 DIZZINESS POSTURAL 139
623 DRUG WITHDRAWAL SYNDROME 139
624 DRUG EFFECT DECREASED 138
625 FULL BLOOD COUNT ABNORMAL 138
626 INFUSION SITE INFECTION 138
627 INTERVERTEBRAL DISC DEGENERATION 138
628 EYE PRURITUS 137
629 ISCHAEMIC STROKE 137
630 RENAL CYST 137
631 URINE OUTPUT DECREASED 137
632 WRONG TECHNIQUE IN DRUG USAGE PROCESS 137
633 ACTIVITIES OF DAILY LIVING IMPAIRED 136
634 DEAFNESS 136
635 HYPERBILIRUBINAEMIA 136
636 SHOCK HAEMORRHAGIC 136
637 BACK DISORDER 135
638 SPUTUM DISCOLOURED 135
639 INJECTION SITE SWELLING 134
640 SYSTEMIC LUPUS ERYTHEMATOSUS 134
641 VITAMIN D DEFICIENCY 134
642 WEIGHT FLUCTUATION 134
643 PSORIATIC ARTHROPATHY 133
644 BENIGN PROSTATIC HYPERPLASIA 132
645 HYPERNATRAEMIA 132
646 BLOOD COUNT ABNORMAL 131
647 COLD SWEAT 131
648 EMOTIONAL DISORDER 131
649 MULTIPLE SCLEROSIS 131
650 NEUTROPHIL COUNT INCREASED 131
651 SPLENOMEGALY 131
652 INFUSION SITE DISCHARGE 130
653 INSURANCE ISSUE 130
654 ISCHAEMIC CARDIOMYOPATHY 130
655 HEPATIC ENCEPHALOPATHY 129
656 NIGHTMARE 129
657 OSTEONECROSIS OF JAW 129
658 WRIST FRACTURE 129
659 ABNORMAL BEHAVIOUR 128
660 ANOREXIA 128
661 DEVICE INFUSION ISSUE 128
662 POOR QUALITY SLEEP 128
663 PRODUCT USE COMPLAINT 128
664 TUMOUR LYSIS SYNDROME 128
665 CONJUNCTIVITIS 127
666 EXPOSURE DURING PREGNANCY 127
667 NOCTURIA 127
668 EOSINOPHILIA 126
669 EXERCISE TOLERANCE DECREASED 126
670 HYDRONEPHROSIS 126
671 LOWER LIMB FRACTURE 126
672 TOOTHACHE 126
673 BRAIN NATRIURETIC PEPTIDE INCREASED 125
674 IMMUNODEFICIENCY 125
675 MOVEMENT DISORDER 125
676 OESOPHAGEAL PAIN 125
677 PNEUMONIA BACTERIAL 125
678 PROTEINURIA 125
679 GLYCOSYLATED HAEMOGLOBIN INCREASED 124
680 LEFT VENTRICULAR HYPERTROPHY 124
681 MICTURITION URGENCY 124
682 PERIPHERAL VASCULAR DISORDER 124
683 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 122
684 PULMONARY THROMBOSIS 122
685 THROAT TIGHTNESS 122
686 TORSADE DE POINTES 122
687 ABDOMINAL PAIN LOWER 121
688 CRYING 121
689 ALTERED STATE OF CONSCIOUSNESS 120
690 PETECHIAE 120
691 PRODUCT PRESCRIBING ERROR 120
692 WOUND INFECTION 120
693 CARDIAC VALVE DISEASE 119
694 IMPAIRED QUALITY OF LIFE 119
695 KNEE ARTHROPLASTY 119
696 OESOPHAGEAL SPASM 119
697 OSTEONECROSIS 119
698 TENDERNESS 119
699 DRUG LEVEL INCREASED 118
700 MUSCLE TWITCHING 118
701 HEPARIN-INDUCED THROMBOCYTOPENIA 117
702 HEPATITIS 117
703 JOINT STIFFNESS 117
704 LIVER INJURY 117
705 CHOKING 116
706 CHROMATURIA 116
707 ESCHERICHIA INFECTION 116
708 METASTASES TO LIVER 116
709 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 116
710 DIABETIC KETOACIDOSIS 115
711 GINGIVAL BLEEDING 115
712 MASS 115
713 PHOTOPHOBIA 115
714 AORTIC VALVE INCOMPETENCE 114
715 BRAIN FOG 114
716 IRRITABLE BOWEL SYNDROME 114
717 PRESCRIBED UNDERDOSE 114
718 RASH GENERALISED 114
719 ACCIDENTAL EXPOSURE TO PRODUCT 113
720 BUNDLE BRANCH BLOCK LEFT 113
721 DIALYSIS 113
722 ERUCTATION 113
723 HAEMODIALYSIS 113
724 POST PROCEDURAL HAEMORRHAGE 113
725 PRURITUS GENERALISED 113
726 PSEUDOMONAS INFECTION 113
727 SCAR 113
728 COMPLICATION ASSOCIATED WITH DEVICE 112
729 INCREASED TENDENCY TO BRUISE 112
730 BEDRIDDEN 111
731 BLOOD CHLORIDE DECREASED 111
732 INJECTION SITE REACTION 111
733 OXYGEN CONSUMPTION INCREASED 111
734 SECRETION DISCHARGE 111
735 SEDATION 111
736 SUPRAVENTRICULAR EXTRASYSTOLES 111
737 DRUG TOXICITY 110
738 HYPOKINESIA 110
739 LEFT VENTRICULAR FAILURE 110
740 NEUROTOXICITY 110
741 PSYCHOTIC DISORDER 110
742 INCONTINENCE 109
743 MYELODYSPLASTIC SYNDROME 109
744 PARKINSONISM 109
745 POLYURIA 109
746 PROSTATE CANCER 109
747 PULSE ABSENT 109
748 ATAXIA 108
749 BURSITIS 108
750 ECCHYMOSIS 108
751 ROTATOR CUFF SYNDROME 108
752 SUBARACHNOID HAEMORRHAGE 108
753 CARPAL TUNNEL SYNDROME 107
754 DEVICE FAILURE 107
755 HEPATOMEGALY 107
756 INFUSION SITE REACTION 107
757 NERVE COMPRESSION 107
758 NEPHROPATHY 106
759 PARKINSON^S DISEASE 106
760 THIRST 106
761 LOCAL SWELLING 105
762 NEUTROPENIC SEPSIS 105
763 PYELONEPHRITIS 105
764 UPPER-AIRWAY COUGH SYNDROME 105
765 BONE DENSITY DECREASED 104
766 MENTAL IMPAIRMENT 104
767 REBOUND ACID HYPERSECRETION 104
768 BRAIN OEDEMA 103
769 CARDIAC FAILURE CHRONIC 103
770 DRUG ABUSE 103
771 ESSENTIAL HYPERTENSION 103
772 FEELING JITTERY 103
773 INTERNATIONAL NORMALISED RATIO DECREASED 103
774 RASH PAPULAR 103
775 SLEEP DISORDER THERAPY 103
776 ABNORMAL DREAMS 102
777 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 102
778 INCREASED APPETITE 102
779 LACERATION 102
780 MOTOR DYSFUNCTION 102
781 RESPIRATORY SYNCYTIAL VIRUS INFECTION 102
782 CYTOPENIA 101
783 SPINAL COMPRESSION FRACTURE 101
784 ANALGESIC THERAPY 100
785 CONGESTIVE CARDIOMYOPATHY 100
786 DECREASED ACTIVITY 100
787 DRUG ADMINISTRATION ERROR 100
788 FLANK PAIN 100
789 HEAD DISCOMFORT 100
790 MULTIPLE FRACTURES 100
791 PROSTATIC SPECIFIC ANTIGEN INCREASED 100
792 RESPIRATORY RATE INCREASED 100
793 ACNE 99
794 ATRIOVENTRICULAR BLOCK 99
795 BRONCHOSPASM 99
796 HAIR COLOUR CHANGES 99
797 HAIR TEXTURE ABNORMAL 99
798 PRODUCT RESIDUE PRESENT 99
799 SKIN INFECTION 99
800 TOOTH INFECTION 99
801 COLON CANCER 98
802 DERMATITIS ATOPIC 98
803 EXTRASYSTOLES 98
804 HEREDITARY ANGIOEDEMA 98
805 LIGAMENT SPRAIN 98
806 LYMPHOPENIA 98
807 METABOLIC ENCEPHALOPATHY 98
808 MYOPATHY 98
809 THERAPY PARTIAL RESPONDER 98
810 CARDIAC PACEMAKER INSERTION 97
811 CATHETER SITE HAEMORRHAGE 97
812 EXTRA DOSE ADMINISTERED 97
813 HAEMORRHAGIC STROKE 97
814 PSYCHOLOGICAL TRAUMA 97
815 SKIN BURNING SENSATION 97
816 SKIN FISSURES 97
817 INITIAL INSOMNIA 96
818 MIDDLE INSOMNIA 96
819 NO THERAPEUTIC RESPONSE 95
820 PRODUCT SUBSTITUTION ISSUE 95
821 SKIN CANCER 95
822 TOOTH ABSCESS 95
823 ACUTE PULMONARY OEDEMA 94
824 BASAL CELL CARCINOMA 94
825 DENTAL CARIES 94
826 DEVICE USE ERROR 94
827 HAEMORRHOIDAL HAEMORRHAGE 94
828 SKIN HAEMORRHAGE 94
829 BLOOD CREATINE INCREASED 93
830 CATHETERISATION CARDIAC 93
831 DERMATITIS 93
832 DRUG THERAPY 93
833 RED CELL DISTRIBUTION WIDTH INCREASED 93
834 DYSLIPIDAEMIA 92
835 METABOLIC ALKALOSIS 92
836 PRODUCT ADMINISTRATION INTERRUPTED 92
837 ATRIOVENTRICULAR BLOCK COMPLETE 91
838 CARDIOACTIVE DRUG LEVEL INCREASED 91
839 INFUSION SITE PRURITUS 91
840 MUSCLE TIGHTNESS 91
841 PAIN OF SKIN 91
842 PERITONITIS BACTERIAL 91
843 RED BLOOD CELL SEDIMENTATION RATE INCREASED 91
844 DIABETIC NEUROPATHY 90
845 EYE INFECTION 90
846 WITHDRAWAL SYNDROME 90
847 CYTOMEGALOVIRUS INFECTION 89
848 DIASTOLIC DYSFUNCTION 89
849 GLOSSODYNIA 89
850 NERVE INJURY 89
851 CATHETER SITE INFECTION 88
852 COMPRESSION FRACTURE 88
853 DELUSION 88
854 ERECTILE DYSFUNCTION 88
855 HAEMOLYTIC ANAEMIA 88
856 INJECTION SITE MASS 88
857 SCOLIOSIS 88
858 TOXIC SKIN ERUPTION 88
859 ANAL INCONTINENCE 87
860 BLOOD THYROID STIMULATING HORMONE INCREASED 87
861 DEVICE DIFFICULT TO USE 87
862 HYPERCAPNIA 87
863 METASTASES TO CENTRAL NERVOUS SYSTEM 87
864 PLEURITIC PAIN 87
865 PROTEIN TOTAL DECREASED 87
866 PURPURA 87
867 THINKING ABNORMAL 87
868 BLADDER DISORDER 86
869 BLOOD GLUCOSE ABNORMAL 86
870 BUNDLE BRANCH BLOCK RIGHT 86
871 CATHETER SITE ERYTHEMA 86
872 DEVICE MAINTENANCE ISSUE 86
873 GROIN PAIN 86
874 INJECTION SITE EXTRAVASATION 86
875 METASTASES TO BONE 86
876 PLATELET COUNT INCREASED 86
877 PULMONARY HAEMORRHAGE 86
878 AZOTAEMIA 85
879 CHOLECYSTITIS ACUTE 85
880 EAR DISCOMFORT 85
881 PERIPHERAL COLDNESS 85
882 STAPHYLOCOCCAL SEPSIS 85
883 AMMONIA INCREASED 84
884 HYPERURICAEMIA 84
885 MUSCLE ATROPHY 84
886 DEVICE BREAKAGE 83
887 LEFT ATRIAL DILATATION 83
888 MOUTH HAEMORRHAGE 83
889 OROPHARYNGEAL DISCOMFORT 83
890 PELVIC FRACTURE 83
891 PERICARDITIS 83
892 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 83
893 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 82
894 EMBOLISM 82
895 HIP ARTHROPLASTY 82
896 LUNG CONSOLIDATION 82
897 NEEDLE ISSUE 82
898 REFUSAL OF TREATMENT BY PATIENT 82
899 TOOTH EXTRACTION 82
900 ANAPHYLACTIC SHOCK 81
901 CARDIAC FLUTTER 81
902 COLITIS ISCHAEMIC 81
903 GASTRIC HAEMORRHAGE 81
904 GASTROINTESTINAL INFECTION 81
905 HEPATOTOXICITY 81
906 INTESTINAL ISCHAEMIA 81
907 JOINT RANGE OF MOTION DECREASED 81
908 SKIN IRRITATION 81
909 TOOTH FRACTURE 81
910 ANGINA UNSTABLE 80
911 AORTIC ANEURYSM 80
912 BLOOD POTASSIUM ABNORMAL 80
913 BRONCHIECTASIS 80
914 ENTEROCOCCAL INFECTION 80
915 GASTRITIS EROSIVE 80
916 IMMUNE SYSTEM DISORDER 80
917 JOINT DISLOCATION 80
918 MOOD ALTERED 80
919 PRODUCT DISTRIBUTION ISSUE 80
920 BLOOD PRESSURE DIASTOLIC DECREASED 79
921 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 79
922 FACIAL PAIN 79
923 APHONIA 78
924 CANDIDIASIS 78
925 CAROTID ARTERY STENOSIS 78
926 GENERALISED TONIC-CLONIC SEIZURE 78
927 HYPOVOLAEMIC SHOCK 78
928 MULTIPLE MYELOMA 78
929 ORAL HERPES 78
930 STAPHYLOCOCCAL BACTERAEMIA 78
931 TOOTH LOSS 78
932 ABDOMINAL TENDERNESS 77
933 ACIDOSIS 77
934 CHEST X-RAY ABNORMAL 77
935 DIVERTICULUM INTESTINAL 77
936 HAEMODYNAMIC INSTABILITY 77
937 LARGE INTESTINE POLYP 77
938 MUSCULOSKELETAL DISORDER 77
939 MYOCLONUS 77
940 NODULE 77
941 PARALYSIS 77
942 PROTEIN URINE PRESENT 77
943 SPINAL OPERATION 77
944 STATUS EPILEPTICUS 77
945 SUDDEN DEATH 77
946 CORONARY ARTERY STENOSIS 76
947 EPILEPSY 76
948 EXOSTOSIS 76
949 HYPOTONIA 76
950 MUSCLE RIGIDITY 76
951 PRODUCT STORAGE ERROR 76
952 PURULENT DISCHARGE 76
953 SQUAMOUS CELL CARCINOMA 76
954 ACUTE CORONARY SYNDROME 75
955 BLOOD DISORDER 75
956 BLOOD GLUCOSE FLUCTUATION 75
957 BOWEL MOVEMENT IRREGULARITY 75
958 ESCHERICHIA URINARY TRACT INFECTION 75
959 IMPAIRED WORK ABILITY 75
960 INTESTINAL PERFORATION 75
961 PEPTIC ULCER 75
962 BLOOD LOSS ANAEMIA 74
963 CATARACT OPERATION 74
964 CHOLECYSTECTOMY 74
965 GINGIVAL PAIN 74
966 HUMERUS FRACTURE 74
967 INJECTION SITE RASH 74
968 LUNG OPACITY 74
969 OBSTRUCTIVE AIRWAYS DISORDER 74
970 OBSTRUCTIVE SLEEP APNOEA SYNDROME 74
971 PANCREATIC CARCINOMA 74
972 SKIN ABRASION 74
973 TEMPERATURE INTOLERANCE 74
974 WALKING AID USER 74
975 HAIR DISORDER 73
976 HYPERTHERMIA 73
977 INFUSION SITE INDURATION 73
978 LOW BIRTH WEIGHT BABY 73
979 PRODUCT PREPARATION ERROR 73
980 STENT PLACEMENT 73
981 ANGER 72
982 ANURIA 72
983 COORDINATION ABNORMAL 72
984 HYPOAESTHESIA ORAL 72
985 OCULAR DISCOMFORT 72
986 SENSORY DISTURBANCE 72
987 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 72
988 CACHEXIA 71
989 EYE DISCHARGE 71
990 FAECAL INCONTINENCE 71
991 FRACTURE 71
992 HEART RATE ABNORMAL 71
993 HYPOTHERMIA 71
994 JOINT EFFUSION 71
995 NEOPLASM 71
996 PNEUMONIA FUNGAL 71
997 POLYP 71
998 PREMATURE DELIVERY 71
999 PRODUCT AVAILABILITY ISSUE 71